Financhill
Back

Freeport-McMoRan Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
59

FCX
Freeport-McMoRan

Last Price:
52.43
Seasonality Move:
1.29%
Sell
37

ITCI
Intra-Cellular Therapies

Last Price:
72.30
Seasonality Move:
4.56%
Buy
59
Freeport-McMoRan (FCX) is a Buy

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $52.41. The Score for FCX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $72.30. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $52.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $72.30
    The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.39 Buy
Relative Strength Index (14 RSI): 69.87 Buy
Chaikin Money Flow: 19237112 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.24 - 50.84) Buy
Bollinger Bands (100): (37.84 - 46.8) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.38 Buy
Relative Strength Index (14 RSI): 53.26 Buy
Chaikin Money Flow: -346308 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.59 - 73.79) Buy
Bollinger Bands (100): (65.08 - 72.16) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.66 Buy
20-day SMA: 49.78 Buy
50-day SMA: 44.8 Buy
200-day SMA: 40.26 Buy
8-day EMA: 50.08 Buy
20-day EMA: 49.03 Buy
50-day EMA: 46.08 Buy
200-day EMA: 41.26 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.98 Sell
20-day SMA: 70.61 Buy
50-day SMA: 69.4 Buy
200-day SMA: 62.33 Buy
8-day EMA: 72.67 Sell
20-day EMA: 71.32 Buy
50-day EMA: 69.65 Buy
200-day EMA: 64.15 Buy

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.05 per share, and an increase next year of $0.55 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):